Browse studies

Find your next paid study

25,415 recruiting studies available now

Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) With Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)

This is a phase II open-label, single-arm, multi-center study of tebentafusp in HLA- A\*0201 positive previously untreated (1L) untreated metastatic uveal mela…

Uveal Melanoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Diwakar DavarNCT06070012

Phase 3

Pre-Operative vs. Post-Operative Stereotactic Radiosurgery for Operative Metastatic Brain Tumors

This phase III trial studies the side effects and how well stereotactic radiosurgery (SRS) works before or after surgery in patients with tumors that has sprea…

Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Mayo ClinicNCT03750227

Phase 3

A Phase 3 Randomized, Multi-Center, Placebo-Controlled, Masked Study to Evaluate the Clinical Efficacy and Safety of Fusidic Acid 1% Viscous Topical Antibiotic Eye Drops for the Treatment of Suspected Bacterial Conjunctivitis

The purpose of this clinical trial is to demonstrate the superiority of fusidic acid 1% over placebo in adults and children with confirmed bacterial conjunctiv…

Bacterial Conjunctivitis

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Baxis Pharmaceuticals, Inc.NCT06911424

Atopic Dermatitis Disease Registry of Adult and Adolescent Patients Initiating or Switching Systemic Treatments

The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance…

Atopic Dermatitis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

SanofiNCT07290803

Phase 3

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants With Amyotrophic Lateral Sclerosis

The goal of this clinical trial is to learn if the drug pridopidine works to treat amyotrophic lateral sclerosis in adults. It will also help to learn about th…

Amyotrophic Lateral Sclerosis

Estimated

~$50 – $2,250

Actual pay is set by the research site.

PrileniaNCT07322003

Changes in Resting Metabolic Rate Following Orthopedic Surgery

This project is intended to determine the magnitude and duration of RMR changes in patients receiving orthopedic surgery. The result will help to guide postope…

Metabolism; Disorder, PostproceduralResting Metabolic RatePost Operative Nutrition

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Kansas Medical CenterNCT06107959

Phase 1

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

This is a Phase I/II open label study of intravenous (IV) infusion of ONC-841 as a single agent or in combination in patients with advanced/metastatic solid tu…

Advanced Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

OncoC4, Inc.NCT06352359

Phase 3

A Phase 3 Multi-center Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children (Age 2 to <12 Years) and Infants (Age 6 Months to <2 Years) With Moderate-to-severe Atopic Dermatitis. The Trial is Randomized, Double-blind, Placebo-controlled, and Parallel-group for Children (Age 2 to <12 Years) and Open-label and Single-group for Infants (Age 6 Months to <2 Years)

The purpose of this trial is to test whether treatment with tralokinumab (administered subcutaneous injections \[SC\]) in combination with topical corticostero…

Atopic Dermatitis

Estimated

~$50 – $2,100

Actual pay is set by the research site.

LEO PharmaNCT06311682

Phase 2

A Randomized Phase II Study to Evaluate the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

This is a phase II, randomized, double-blinded, placebo-controlled trial designed to evaluate the efficacy of fezolinetant (45 mg a day) vs. placebo in reducin…

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Yale UniversityNCT06917313

Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients

This study will determine reference range intervals for the parameters reported by the Quantra System with the QPlus Cartridge in pediatric patients.

PediatricCoagulation

Estimated

~$10 – $1,050

Actual pay is set by the research site.

HemoSonics LLCNCT07447713

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Metabolism Research

The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their…

Obesity

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Bettina MittendorferNCT06286761

Observational

Comparison of Surgical Techniques to Treat Isolated Gingival Recession in Mandibular Incisors: A Randomized Clinical Trial

The primary objective of this randomized clinical trial is to compare the mean root coverage achieved with Coronally Advanced Flap (CAF) + Connective Tissue Gr…

Recession, Gingival

Estimated

~$10 – $750

Actual pay is set by the research site.

Case Western Reserve UniversityNCT06037161